Arcturus Therapeutics Holdings (ARCT) Return on Sales: 2019-2025
Historic Return on Sales for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to -0.68%.
- Arcturus Therapeutics Holdings' Return on Sales fell 29.00% to -0.68% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.68%, marking a year-over-year decrease of 29.00%. This contributed to the annual value of -0.53% for FY2024, which is 35.00% down from last year.
- According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Return on Sales is -0.68%, which was down 38.74% from -0.49% recorded in Q2 2025.
- Arcturus Therapeutics Holdings' Return on Sales' 5-year high stood at 0.40% during Q1 2023, with a 5-year trough of -22.30% in Q3 2021.
- Its 3-year average for Return on Sales is -0.27%, with a median of -0.44% in 2024.
- In the last 5 years, Arcturus Therapeutics Holdings' Return on Sales tumbled by 1,731bps in 2021 and then soared by 1,947bps in 2022.
- Arcturus Therapeutics Holdings' Return on Sales (Quarterly) stood at -16.41% in 2021, then spiked by 1,646bps to 0.05% in 2022, then decreased by 23bps to -0.18% in 2023, then plummeted by 35bps to -0.53% in 2024, then dropped by 29bps to -0.68% in 2025.
- Its Return on Sales stands at -0.68% for Q3 2025, versus -0.49% for Q2 2025 and -0.47% for Q1 2025.